Zuhong He
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Zuhong He has a total of 419 co-authors. Here are the top co-authors by number of shared publications:
Shengyu Zou
Department of Pathology and Laboratory Medicine The Medical University of South Carolina Charleston South Carolina USA
11 shared publications- Renjie Chai
Frontier Interdisciplinary Domain, Beijing Institute of Technology, Zhuhai, China
10 shared publications - Wei-Jia Kong
Department of Otorhinolaryngology Union Hospital Tongji Medical College Huazhong University of Science and Technology Wuhan P. R. China
8 shared publications - Xiong Chen
Department of Otorhinolaryngology, Head and Neck Surgery, Zhongnan Hospital of Wuhan University, Wuhan, China
5 shared publications Bowen Xu
Department of Otorhinolaryngology-Head and Neck Surgery, Zhongnan Hospital of Wuhan University
3 shared publicationsChunjiang Wei
Department of Otorhinolaryngology-Head and Neck Surgery, Zhongnan Hospital of Wuhan University
3 shared publications
Latest Publications
- Open Access
m6A ‐Related Regulation of Ferroptosis Contributes to Nasal Epithelial Barrier Dysfunction in Allergic Rhinitis
Background: Ferroptosis is a non‐apoptotic form of cell death driven by lipid peroxidation. Although elevated lipid peroxidation has been linked to respiratory epithelial injury, its role in allergic rhinitis (AR) remains unclear. Therefore, in this study, we aimed to assess the role of ferroptosis in AR pathogenesis and elucidate its molecular mechanism. Methods: Human nasal epithelial cells (HNEpC and RPMI‐2650) and Balb/c mice were used to evaluate house dust mite (HDM)‐induced ferroptosis related responses and nasal epithelial barrier disruption. Clinical nasal mucosal samples were collected to validate key experimental findings. N6‐methyladenosine (m6A) methylation levels were assessed by m 6 A assays and dot blot analysis, predicted m 6 A sites were identified using SRAMP, and RIP‐qPCR and MeRIP‐qPCR were performed to examine RNA–protein interactions and site‐specific m6A enrichment, respectively. Results: HDM exposure induced lipid peroxidation–driven ferroptosis‐related epithelial barrier disruption. Glutathione peroxidase 4 (GPX4) acted as a protective regulator, as ferroptosis inhibition or GPX4 overexpression alleviated epithelial damage. Growth arrest‐specific 1 (GAS1) promoted ferroptosis by suppressing GPX4 expression, a finding further supported by in vivo validation in GAS1‐knockdown mice. Mechanistically, this GAS1–GPX4 regulatory relationship was linked to METTL3‐mediated m 6 A modification of GPX4 mRNA at the site 625. Conclusions: These findings suggest a novel mechanism whereby HDM exposure promotes ferroptosis‐related nasal epithelial barrier impairment through GAS1–METTL3–mediated regulation of GPX4 m 6 A methylation, thereby contributing to AR pathogenesis.
Open Accessm6A ‐Related Regulation of Ferroptosis Contributes to Nasal Epithelial Barrier Dysfunction in Allergic Rhinitis
Background: Ferroptosis is a non‐apoptotic form of cell death driven by lipid peroxidation. Although elevated lipid peroxidation has been linked to respiratory epithelial injury, its role in allergic rhinitis (AR) remains unclear. Therefore, in this study, we aimed to assess the role of ferroptosis in AR pathogenesis and elucidate its molecular mechanism. Methods: Human nasal epithelial cells (HNEpC and RPMI‐2650) and Balb/c mice were used to evaluate house dust mite (HDM)‐induced ferroptosis related responses and nasal epithelial barrier disruption. Clinical nasal mucosal samples were collected to validate key experimental findings. N6‐methyladenosine (m6A) methylation levels were assessed by m 6 A assays and dot blot analysis, predicted m 6 A sites were identified using SRAMP, and RIP‐qPCR and MeRIP‐qPCR were performed to examine RNA–protein interactions and site‐specific m6A enrichment, respectively. Results: HDM exposure induced lipid peroxidation–driven ferroptosis‐related epithelial barrier disruption. Glutathione peroxidase 4 (GPX4) acted as a protective regulator, as ferroptosis inhibition or GPX4 overexpression alleviated epithelial damage. Growth arrest‐specific 1 (GAS1) promoted ferroptosis by suppressing GPX4 expression, a finding further supported by in vivo validation in GAS1‐knockdown mice. Mechanistically, this GAS1–GPX4 regulatory relationship was linked to METTL3‐mediated m 6 A modification of GPX4 mRNA at the site 625. Conclusions: These findings suggest a novel mechanism whereby HDM exposure promotes ferroptosis‐related nasal epithelial barrier impairment through GAS1–METTL3–mediated regulation of GPX4 m 6 A methylation, thereby contributing to AR pathogenesis.
- Open Access
- 10 June 2026
- Published by Wiley in Sensory Neuroscience
- Vol. 2 (2)
AMPKα Silencing Prevents Kanamycin‐Induced Ototoxicity in an Acute Mouse Model
Kanamycin (KM), a widely used aminoglycoside antibiotic, is limited by its ototoxic side effects, primarily targeting cochlear outer hair cells (OHCs) and leading to irreversible sensorineural hearing loss. Our previous work showed that silencing AMP‐activated protein kinase alpha 1 (AMPKα1) prevents noise‐induced hearing loss through a redox‐sensitive regulatory mechanism. Given that both noise‐induced and aminoglycoside‐induced hearing loss share oxidative stress as a key pathological feature, we tested whether AMPKα1 silencing could mitigate KM‐induced damage using an acute ototoxic model combining KM with furosemide (KM + FU). KM + FU exposure markedly increased AMPKα phosphorylation at Thr172. Targeted siRNA‐mediated silencing via posterior semicircular canal delivery in CBA/J mice significantly reduced AMPKα1 expression in OHCs and effectively prevented KM + FU‐induced OHC loss and hearing impairment. This preventive effect was independent of stria vascularis permeability or cochlear KM uptake. These findings identify AMPKα as a contributor to KM + FU‐induced acute ototoxicity and suggest that its inhibition may be a promising strategy for hearing preservation.
- 10 June 2026
- Published by Wiley in Sensory Neuroscience
- Vol. 2 (2)
Open AccessAMPKα Silencing Prevents Kanamycin‐Induced Ototoxicity in an Acute Mouse Model
Kanamycin (KM), a widely used aminoglycoside antibiotic, is limited by its ototoxic side effects, primarily targeting cochlear outer hair cells (OHCs) and leading to irreversible sensorineural hearing loss. Our previous work showed that silencing AMP‐activated protein kinase alpha 1 (AMPKα1) prevents noise‐induced hearing loss through a redox‐sensitive regulatory mechanism. Given that both noise‐induced and aminoglycoside‐induced hearing loss share oxidative stress as a key pathological feature, we tested whether AMPKα1 silencing could mitigate KM‐induced damage using an acute ototoxic model combining KM with furosemide (KM + FU). KM + FU exposure markedly increased AMPKα phosphorylation at Thr172. Targeted siRNA‐mediated silencing via posterior semicircular canal delivery in CBA/J mice significantly reduced AMPKα1 expression in OHCs and effectively prevented KM + FU‐induced OHC loss and hearing impairment. This preventive effect was independent of stria vascularis permeability or cochlear KM uptake. These findings identify AMPKα as a contributor to KM + FU‐induced acute ototoxicity and suggest that its inhibition may be a promising strategy for hearing preservation.
- Open Access
- 8 May 2026
- Published by Frontiers Media SA in Frontiers in Molecular Neuroscience
- Vol. 19, 1834102
The H3K9me2-FOXG1-microRNA axis reduces cochlear hair cells damage by modulating autophagy in age-related hearing loss
Age-related hearing loss (ARHL) is a growing global health concern due to its irreversibility and multifactorial pathogenesis. Epigenetic alterations are emerging as key drivers of aging, yet the mechanisms underlying their contribution to ARHL remain poorly understood. Here, we identified the histone H3 lysine 9 dimethylation (H3K9me2)-forkhead box G1 (FOXG1)-microRNA axis as a crucial regulator of auditory degeneration through modulation of autophagy. Using in vivo and in vitro D-galactose-induced aging models, we observed that H3K9me2 levels exhibited an inverse relationship with FOXG1 expression in cochlear hair cells. FOXG1 regulated autophagy by controlling autophagy-related microRNAs, thereby modulating reactive oxygen species accumulation and apoptosis in aging hair cells. Furthermore, a multi-omics approach delineated the broader FOXG1-mediated regulatory network driving ARHL. To our knowledge, this is the first study to comprehensively characterize the epigenetic regulation of autophagy by FOXG1 in ARHL, providing new mechanistic insights into cochlear hair cell aging and potential therapeutic targets.
- 8 May 2026
- Published by Frontiers Media SA in Frontiers in Molecular Neuroscience
- Vol. 19, 1834102
Open AccessThe H3K9me2-FOXG1-microRNA axis reduces cochlear hair cells damage by modulating autophagy in age-related hearing loss
Age-related hearing loss (ARHL) is a growing global health concern due to its irreversibility and multifactorial pathogenesis. Epigenetic alterations are emerging as key drivers of aging, yet the mechanisms underlying their contribution to ARHL remain poorly understood. Here, we identified the histone H3 lysine 9 dimethylation (H3K9me2)-forkhead box G1 (FOXG1)-microRNA axis as a crucial regulator of auditory degeneration through modulation of autophagy. Using in vivo and in vitro D-galactose-induced aging models, we observed that H3K9me2 levels exhibited an inverse relationship with FOXG1 expression in cochlear hair cells. FOXG1 regulated autophagy by controlling autophagy-related microRNAs, thereby modulating reactive oxygen species accumulation and apoptosis in aging hair cells. Furthermore, a multi-omics approach delineated the broader FOXG1-mediated regulatory network driving ARHL. To our knowledge, this is the first study to comprehensively characterize the epigenetic regulation of autophagy by FOXG1 in ARHL, providing new mechanistic insights into cochlear hair cell aging and potential therapeutic targets.
- 30 March 2026
- Published by American Chemical Society (ACS) in ACS Nano
- Vol. 20 (14) , 11397-11408
Developing Inner Ear Organoids in Ultrasound-Activated Piezoelectric Hydrogel for Assessing Ototoxicity
Organoids are capable of recapitulating complex cellular structures and functions, making them valuable tools for drug evaluation, while their use in vitro differentiation of organoids for identifying drug candidates aimed at treating hearing and balance dysfunction remains relatively underexplored. In this study, we present the directed self-organization of human induced pluripotent stem cells within the barium titanate-doped GelMA hydrogel, which promotes the differentiation of inner ear organoids (IEOs) featuring highly differentiated auditory neurons. The hydrogel acting as a sustained source of piezoelectric potential could generate electrical stimulation upon exposure to ultrasonics, thereby facilitating the rapid differentiation and maturation of auditory neurons within IEOs. The bioengineered IEOs form multiple otic-vesicle-like structures and further develop into functional hair cells and sensory neurons. Furthermore, we explored the potential of this model for drug testing, demonstrating that resveratrol effectively mitigates cisplatin-induced toxicity in hair cells and sensory neurons within IEOs. Our electrical stimulation-based approach provides a promising platform for constructing more reliable and functional IEOs, which could serve as an innovative drug screening system for the prevention of cisplatin-induced ototoxicity and neuropathy.
- 30 March 2026
- Published by American Chemical Society (ACS) in ACS Nano
- Vol. 20 (14) , 11397-11408
Developing Inner Ear Organoids in Ultrasound-Activated Piezoelectric Hydrogel for Assessing Ototoxicity
Organoids are capable of recapitulating complex cellular structures and functions, making them valuable tools for drug evaluation, while their use in vitro differentiation of organoids for identifying drug candidates aimed at treating hearing and balance dysfunction remains relatively underexplored. In this study, we present the directed self-organization of human induced pluripotent stem cells within the barium titanate-doped GelMA hydrogel, which promotes the differentiation of inner ear organoids (IEOs) featuring highly differentiated auditory neurons. The hydrogel acting as a sustained source of piezoelectric potential could generate electrical stimulation upon exposure to ultrasonics, thereby facilitating the rapid differentiation and maturation of auditory neurons within IEOs. The bioengineered IEOs form multiple otic-vesicle-like structures and further develop into functional hair cells and sensory neurons. Furthermore, we explored the potential of this model for drug testing, demonstrating that resveratrol effectively mitigates cisplatin-induced toxicity in hair cells and sensory neurons within IEOs. Our electrical stimulation-based approach provides a promising platform for constructing more reliable and functional IEOs, which could serve as an innovative drug screening system for the prevention of cisplatin-induced ototoxicity and neuropathy.
- 4 March 2026
- Published by Wiley in Advanced Materials
- Vol. 38 (18)
Multifunctional Self‐Assembling Peptide System for Preventing Noise‐Induced Hearing Loss
Functional self‐assembling peptides prepared by linking short functional peptides to basic self‐assembling peptides via solid‐phase synthesis are often single‐function and insufficient for preventing complex diseases, including noise‐induced hearing loss (NIHL). Herein, a strategy to design multifunctional self‑assembling peptides (NPR36) for preventing NIHL is presented. Compared to the conventional approach of constructing multifunctional self‐assembling peptide systems through co‐assembling distinct functional peptides, this strategy integrates multiple functions into a single self‐assembling peptide by conjugating multifunctional hormone‐derived peptides with extended basic self‐assembling peptides. This monolithic integration eliminates the need to balance concentration ratios and prevents efficacy loss that occurs when the concentration of any component drops below its therapeutic threshold, while also ensuring that each peptide possesses complete multifunctionality, thereby enhancing therapeutic effects. Benefiting from the non‐covalent interactions of the extended assembly motif, NPR36 self‑assembling peptides can form nanofibers and achieve sustained release during disassembly, maintaining an effective concentration at the treatment site. Furthermore, a fiber‐microalgae complex was formed by combining NPR36 with Spirulina platensis. This fiber‐microalgae‐based system synergistically exerted antioxidant and anti‐apoptotic effects, markedly reducing hair cell loss and restoring hearing. Overall, preventive interventions based on multifunctional self‐assembling peptides could overcome the clinical translation challenges in the prevention of inner ear disorders.
- 4 March 2026
- Published by Wiley in Advanced Materials
- Vol. 38 (18)
Multifunctional Self‐Assembling Peptide System for Preventing Noise‐Induced Hearing Loss
Functional self‐assembling peptides prepared by linking short functional peptides to basic self‐assembling peptides via solid‐phase synthesis are often single‐function and insufficient for preventing complex diseases, including noise‐induced hearing loss (NIHL). Herein, a strategy to design multifunctional self‑assembling peptides (NPR36) for preventing NIHL is presented. Compared to the conventional approach of constructing multifunctional self‐assembling peptide systems through co‐assembling distinct functional peptides, this strategy integrates multiple functions into a single self‐assembling peptide by conjugating multifunctional hormone‐derived peptides with extended basic self‐assembling peptides. This monolithic integration eliminates the need to balance concentration ratios and prevents efficacy loss that occurs when the concentration of any component drops below its therapeutic threshold, while also ensuring that each peptide possesses complete multifunctionality, thereby enhancing therapeutic effects. Benefiting from the non‐covalent interactions of the extended assembly motif, NPR36 self‑assembling peptides can form nanofibers and achieve sustained release during disassembly, maintaining an effective concentration at the treatment site. Furthermore, a fiber‐microalgae complex was formed by combining NPR36 with Spirulina platensis. This fiber‐microalgae‐based system synergistically exerted antioxidant and anti‐apoptotic effects, markedly reducing hair cell loss and restoring hearing. Overall, preventive interventions based on multifunctional self‐assembling peptides could overcome the clinical translation challenges in the prevention of inner ear disorders.
- Open Access
- 21 October 2025
- Published by Springer Nature in Neuroscience Bulletin
- Vol. 42 (1) , 221-232
Inner Ear Organoids: A Hydrogel-Based Platform for Drug Screening and Deafness Modeling
This review highlights advances in inner ear organoids (IEOs) as a novel platform for drug screening and disease modeling, particularly for hearing loss. IEOs, derived from embryonic stem cells, induced pluripotent stem cells, or tissue-specific progenitors, provide a physiologically relevant alternative to traditional animal models. Significant progress has been made in utilizing various cell sources, extracellular matrix materials such as Matrigel and hydrogels, and methods for controlling microenvironments through biochemical and biophysical signals. Applications of IEOs in drug screening, disease modeling, and personalized medicine enable exploration of hearing loss mechanisms and therapeutic testing. However, challenges remain, including the incomplete maturation of cochlear cells and difficulty replicating in vivo environments. Future research should focus on optimizing IEO generation, incorporating microfluidic technologies, and advancing high-throughput screening to enhance drug discovery and clinical translation.
- 21 October 2025
- Published by Springer Nature in Neuroscience Bulletin
- Vol. 42 (1) , 221-232
Open AccessInner Ear Organoids: A Hydrogel-Based Platform for Drug Screening and Deafness Modeling
This review highlights advances in inner ear organoids (IEOs) as a novel platform for drug screening and disease modeling, particularly for hearing loss. IEOs, derived from embryonic stem cells, induced pluripotent stem cells, or tissue-specific progenitors, provide a physiologically relevant alternative to traditional animal models. Significant progress has been made in utilizing various cell sources, extracellular matrix materials such as Matrigel and hydrogels, and methods for controlling microenvironments through biochemical and biophysical signals. Applications of IEOs in drug screening, disease modeling, and personalized medicine enable exploration of hearing loss mechanisms and therapeutic testing. However, challenges remain, including the incomplete maturation of cochlear cells and difficulty replicating in vivo environments. Future research should focus on optimizing IEO generation, incorporating microfluidic technologies, and advancing high-throughput screening to enhance drug discovery and clinical translation.
- 9 September 2025
- Published by Springer Nature in Nature Aging
- Vol. 5 (9) , 1669-1685
The X-Age Project to construct a Chinese aging clock
The global surge in the population of people 60 years and older, including that in China, challenges healthcare systems with rising age‐related diseases. To address this demographic change, the Aging Biomarker Consortium (ABC) has launched the X-Age Project to develop a comprehensive aging evaluation system tailored to the Chinese population. Our goal is to identify robust biomarkers and construct composite aging clocks that capture biological age, defined as an individual’s physiological and molecular state, across diverse Chinese cohorts. This Perspective outlines the core objectives, methodological framework and key deliverables of the X-Age Project, including cohort recruitment, standardized sample collection, multimodal data acquisition and clock model development. By integrating interdisciplinary expertise, we aim to provide a practical and scalable platform for understanding aging complexity and heterogeneity, early detection of accelerated aging and evaluation of aging interventions.
- 9 September 2025
- Published by Springer Nature in Nature Aging
- Vol. 5 (9) , 1669-1685
The X-Age Project to construct a Chinese aging clock
The global surge in the population of people 60 years and older, including that in China, challenges healthcare systems with rising age‐related diseases. To address this demographic change, the Aging Biomarker Consortium (ABC) has launched the X-Age Project to develop a comprehensive aging evaluation system tailored to the Chinese population. Our goal is to identify robust biomarkers and construct composite aging clocks that capture biological age, defined as an individual’s physiological and molecular state, across diverse Chinese cohorts. This Perspective outlines the core objectives, methodological framework and key deliverables of the X-Age Project, including cohort recruitment, standardized sample collection, multimodal data acquisition and clock model development. By integrating interdisciplinary expertise, we aim to provide a practical and scalable platform for understanding aging complexity and heterogeneity, early detection of accelerated aging and evaluation of aging interventions.
- Open Access
- 31 March 2025
- Published by OAE Publishing Inc. in Ageing and Neurodegenerative Diseases
- Vol. 5 (1)
Age-related hearing loss: the complex interaction of carbohydrate metabolism in auditory and cognitive dysfunction during aging
Age-related hearing loss (ARHL) is an extremely widespread form of age-related disease mainly characterized by high-frequency hearing loss and subsequent cognitive dysfunction. The pathological changes associated with ARHL involve both peripheral auditory structures and the central nervous system. Recent studies have focused on the aging mechanisms of peripheral auditory sensors, such as cochlear hair cells, spiral ganglion cells, and the stria vascularis. Additionally, the role of carbohydrate metabolic signaling pathways in ARHL has garnered attention, particularly the regulatory effects of glycolysis, the glycosylation pathway, and the pentose phosphate pathway. Additionally, cognitive dysfunction is a significant clinical symptom in the advanced stages of ARHL, and growing evidence suggests that ARHL may be closely linked to Alzheimer’s disease, potentially serving as a risk factor for its development. In this review, we summarize the specific regulators and metabolic pathways of carbohydrate metabolism that contribute to ARHL. Furthermore, we discuss recent research progress on the relationship between carbohydrate metabolism, hearing loss, and cognitive dysfunction in ARHL. Finally, we explore novel therapeutic targets and future prospects for understanding the pathogenesis and clinical diagnosis of ARHL and related aging-associated diseases.
- 31 March 2025
- Published by OAE Publishing Inc. in Ageing and Neurodegenerative Diseases
- Vol. 5 (1)
Open AccessAge-related hearing loss: the complex interaction of carbohydrate metabolism in auditory and cognitive dysfunction during aging
Age-related hearing loss (ARHL) is an extremely widespread form of age-related disease mainly characterized by high-frequency hearing loss and subsequent cognitive dysfunction. The pathological changes associated with ARHL involve both peripheral auditory structures and the central nervous system. Recent studies have focused on the aging mechanisms of peripheral auditory sensors, such as cochlear hair cells, spiral ganglion cells, and the stria vascularis. Additionally, the role of carbohydrate metabolic signaling pathways in ARHL has garnered attention, particularly the regulatory effects of glycolysis, the glycosylation pathway, and the pentose phosphate pathway. Additionally, cognitive dysfunction is a significant clinical symptom in the advanced stages of ARHL, and growing evidence suggests that ARHL may be closely linked to Alzheimer’s disease, potentially serving as a risk factor for its development. In this review, we summarize the specific regulators and metabolic pathways of carbohydrate metabolism that contribute to ARHL. Furthermore, we discuss recent research progress on the relationship between carbohydrate metabolism, hearing loss, and cognitive dysfunction in ARHL. Finally, we explore novel therapeutic targets and future prospects for understanding the pathogenesis and clinical diagnosis of ARHL and related aging-associated diseases.
- Open Access
- 1 February 2025
- Published by Oxford University Press (OUP) in Life Medicine
- Vol. 4 (1) , lnaf011
A biomarker framework for auditory system aging: the Aging Biomarker Consortium consensus statement
Hearing is one of the most vital sensory functions in human beings and a crucial means of perceiving and acquiring information from the natural environment. The advancement of human society is closely linked to the development of language, with hearing serving as the foundation for verbal communication. As individuals age, the deterioration of the auditory system becomes a significant factor contributing to sensory impairments in the elderly. In addition to hearing loss, the aging of the auditory system is also associated with cognitive decline and psychosocial disorders, which severely impact the quality of life for older adults. Currently, there are no effective treatments or interventions available for addressing the aging of the auditory system. Therefore, identifying biomarkers of the auditory system aging is of great significance. The Aging Biomarker Consortium of China has conducted a comprehensive evaluation of aging biomarkers in the auditory system, focusing on three dimensions: morphological, functional, and humoral biomarkers. This initiative aims to establish a foundation for assessing the degree of aging in the auditory system and to promote the management of auditory health in an aging society, ultimately enhancing the auditory health of the elderly population both in China and globally.
- 1 February 2025
- Published by Oxford University Press (OUP) in Life Medicine
- Vol. 4 (1) , lnaf011
Open AccessA biomarker framework for auditory system aging: the Aging Biomarker Consortium consensus statement
Hearing is one of the most vital sensory functions in human beings and a crucial means of perceiving and acquiring information from the natural environment. The advancement of human society is closely linked to the development of language, with hearing serving as the foundation for verbal communication. As individuals age, the deterioration of the auditory system becomes a significant factor contributing to sensory impairments in the elderly. In addition to hearing loss, the aging of the auditory system is also associated with cognitive decline and psychosocial disorders, which severely impact the quality of life for older adults. Currently, there are no effective treatments or interventions available for addressing the aging of the auditory system. Therefore, identifying biomarkers of the auditory system aging is of great significance. The Aging Biomarker Consortium of China has conducted a comprehensive evaluation of aging biomarkers in the auditory system, focusing on three dimensions: morphological, functional, and humoral biomarkers. This initiative aims to establish a foundation for assessing the degree of aging in the auditory system and to promote the management of auditory health in an aging society, ultimately enhancing the auditory health of the elderly population both in China and globally.